81 FR 96026 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 250 (December 29, 2016)

Page Range		96026-96027
FR Document		2016-31565

Federal Register, Volume 81 Issue 250 (Thursday, December 29, 2016)

[Federal Register Volume 81, Number 250 (Thursday, December 29, 2016)]
[Notices]
[Pages 96026-96027]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-31565]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; NIH Big Data to Knowledge (BD2K) Enhancing Diversity in 
Biomedical Data.
    Date: January 23, 2017.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Delia Olufokunbi Sam, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3158, MSC 7770, Bethesda, MD 
20892, 301-435-0684, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: Mammalian Models for Translational Research.
    Date: January 24, 2017.
    Time: 2:30 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Sharon K Gubanich, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6195D, MSC 7804, Bethesda, MD 
20892, (301) 408-9512, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: High Throughput Screening.
    Date: January 26, 2017.
    Time: 9:00 a.m. to 6:00 p.m.

[[Page 96027]]

    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: David Filpula, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6181, MSC 7892, Bethesda, MD 20892, 301-435-
2902, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR 16-116: Bioengineering Research Partnerships (BRP).
    Date: January 27, 2017.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Contact Person: Songtao Liu, MD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5108, Bethesda, MD 20817, 301-435-3578, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: December 23, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-31565 Filed 12-28-16; 8:45 am]
BILLING CODE 4140-01-P

96026 Federal Register / Vol. 81, No. 250 / Thursday, December 29, 2016 / Notices

Toxicology. Interested persons may visit this Web page to stay abreast of the Dated: December 19, 2016.
participate via Adobe Connect. Time most current webinar information. John R. Bucher,
will be allotted for questions from the Individuals with disabilities who Associate Director, National Toxicology
audience. need accommodation to participate in Program.
DATES: Webinar: January 24, 2017, 1:00 this event should contact Cameron Clark [FR Doc. 2016–31439 Filed 12–28–16; 8:45 am]
p.m. to approximately 2:30 p.m. Eastern at phone: (919) 541–4086 or email: BILLING CODE 4140–01–P
Standard Time (EST). clark.cameron@epa.gov. TTY users
Registration for Webinar: Registration should contact the Federal TTY Relay
is open through 2:30 p.m. on January 24, Service at (800) 877–8339. Requests DEPARTMENT OF HEALTH AND
2017. should be made at least five business HUMAN SERVICES
ADDRESSES: Webinar Web page: http:// days in advance of the event. National Institutes of Health
ntp.niehs.nih.gov/go/commprac-2017.
Background Information on ICCVAM
FOR FURTHER INFORMATION CONTACT: Dr. Center for Scientific Review; Notice of
and NICEATM: ICCVAM is an
Warren Casey, Director, NICEATM; Closed Meetings
interagency committee composed of
email: warren.casey@nih.gov; telephone:
representatives from 15 federal Pursuant to section 10(d) of the
(919) 316–4729.
regulatory and research agencies that Federal Advisory Committee Act, as
SUPPLEMENTARY INFORMATION:
require, use, generate, or disseminate amended (5 U.S.C. App.), notice is
Background: ICCVAM promotes the
toxicological and safety testing hereby given of the following meetings.
development and validation of toxicity
information. ICCVAM conducts The meetings will be closed to the
testing methods that protect human
technical evaluations of new, revised, public in accordance with the
health and the environment while
and alternative safety testing methods provisions set forth in sections
replacing, reducing, or refining animal
use. ICCVAM also provides guidance to and integrated testing strategies with 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
test method developers and facilitates regulatory applicability and promotes as amended. The grant applications and
collaborations that promote the the scientific validation and regulatory the discussions could disclose
development of new test methods. To acceptance of testing methods that more confidential trade secrets or commercial
address these goals, ICCVAM will hold accurately assess the safety and hazards property such as patentable material,
a Communities of Practice webinar on of chemicals and products and replace, and personal information concerning
‘‘Incorporating Chemical Information: reduce, or refine (enhance animal well- individuals associated with the grant
Resources, Limitations, and being and lessen or avoid pain and applications, the disclosure of which
Characterizing the Domain of distress) animal use. The ICCVAM would constitute a clearly unwarranted
Applicability for 21st Century Toxicity Authorization Act of 2000 (42 U.S.C. invasion of personal privacy.
Testing.’’ 285l–3) establishes ICCVAM as a Name of Committee: Center for Scientific
This webinar will emphasize the permanent interagency committee of the Review Special Emphasis Panel; NIH Big
importance of understanding the National Institute of Environmental Data to Knowledge (BD2K) Enhancing
structural and functional diversity of Health Sciences and provides the Diversity in Biomedical Data.
chemicals used in developing and authority for ICCVAM involvement in Date: January 23, 2017.
validating alternative approaches to activities relevant to the development of Time: 12:00 p.m. to 4:00 p.m.
traditional in vivo toxicology test alternative test methods. ICCVAM acts Agenda: To review and evaluate grant
applications.
methods. It will also feature next to ensure that new and revised test
Place: National Institutes of Health, 6701
generation chemoinformatics methods are validated to meet the needs Rockledge Drive, Bethesda, MD 20892
techniques, which are being used to of federal agencies, increase the (Virtual Meeting).
fully characterize chemical lists, and efficiency and effectiveness of federal Contact Person: Delia Olufokunbi Sam,
highlight case studies where such agency test method review, and Ph.D., Scientific Review Officer, Center for
techniques have been successfully optimize utilization of scientific Scientific Review, National Institutes of
applied. expertise outside the federal Health, 6701 Rockledge Drive, Room 3158,
The ICCVAM webinar will feature government. Additional information MSC 7770, Bethesda, MD 20892, 301–435–
presentations by two experts on 0684, olufokunbisamd@csr.nih.gov.
about ICCVAM can be found at http://
characterizing the domain of Name of Committee: Center for Scientific
ntp.niehs.nih.gov/go/iccvam.
applicability for validation of high Review Special Emphasis Panel; PAR Panel:
throughput test methods and strategies. NICEATM administers ICCVAM, Mammalian Models for Translational
The preliminary agenda and additional provides scientific and operational Research.
support for ICCVAM-related activities, Date: January 24, 2017.
information about presentations will be Time: 2:30 p.m. to 6:00 p.m.
posted at http://ntp.niehs.nih.gov/go/ and conducts and publishes analyses
Agenda: To review and evaluate grant
commprac-2017 as available. and evaluations of data from new,
applications.
Webinar and Registration: This revised, and alternative testing Place: National Institutes of Health, 6701
webinar is open to the public with time approaches. NICEATM and ICCVAM Rockledge Drive, Bethesda, MD 20892
scheduled for questions by participants work collaboratively to evaluate new (Virtual Meeting).
following each presentation. and improved testing approaches Contact Person: Sharon K Gubanich, Ph.D.,
Registration for the webinar is required applicable to the needs of U.S. federal Scientific Review Officer, Center for
asabaliauskas on DSK3SPTVN1PROD with NOTICES

and is open through 2:30 p.m. on agencies. NICEATM and ICCVAM Scientific Review, National Institutes of
welcome the public nomination of new, Health, 6701 Rockledge Drive, Room 6195D,
January 24, 2017. Registration is MSC 7804, Bethesda, MD 20892, (301) 408–
available at http://ntp.niehs.nih.gov/go/ revised, and alternative test methods 9512, gubanics@csr.nih.gov.
commprac-2017. Registrants will and strategies for validation studies and
Name of Committee: Center for Scientific
receive instructions on how to access technical evaluations. Additional Review Special Emphasis Panel; PAR Panel:
and participate in the webinar in the information about NICEATM can be High Throughput Screening.
email confirming their registration. found at http://ntp.niehs.nih.gov/go/ Date: January 26, 2017.
Interested individuals are encouraged to niceatm. Time: 9:00 a.m. to 6:00 p.m.

VerDate Sep<11>2014 18:41 Dec 28, 2016 Jkt 241001 PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 E:\FR\FM\29DEN1.SGM 29DEN1

Federal Register / Vol. 81, No. 250 / Thursday, December 29, 2016 / Notices 96027

Agenda: To review and evaluate grant Agenda: To review and evaluate grant Name of Committee: National Institute of
applications. applications. Allergy and Infectious Diseases Special
Place: National Institutes of Health, 6701 Place: National Institute on Aging, Emphasis Panel NIAID Clinical Trial
Rockledge Drive, Bethesda, MD 20892 Gateway Building, Suite 2W200, 7201 Planning Grants (R34)
(Virtual Meeting). Wisconsin Avenue, Bethesda, MD 20892 Date: January 24, 2017.
Contact Person: David Filpula, Ph.D., (Telephone Conference Call). Time: 1:00 p.m. to 4:00 p.m.
Scientific Review Officer, Center for Contact Person: Anita H. Undale, Ph.D., Agenda: To review and evaluate grant
Scientific Review, National Institutes of MD, Scientific Review Officer, Scientific applications.
Health, 6701 Rockledge Drive, Room 6181, Review Branch, National Institute on Aging, Place: National Institutes of Health, 6120
MSC 7892, Bethesda, MD 20892, 301–435– Gateway Building, Suite 2W200, 7201 Executive Blvd., Rockville, MD 20852,
2902, filpuladr@mail.nih.gov. Wisconsin Avenue, Bethesda, MD 20892, (Telephone Conference Call).
Name of Committee: Center for Scientific 240–747–7825, anita.undale@nih.gov. Contact Person: Paul A. Amstad, Ph.D.,
Review Special Emphasis Panel; PAR 16– Scientific Review Officer, Scientific Review
This notice is being published less than 15
116: Bioengineering Research Partnerships Program, Division of Extramural Activities,
days prior to the meeting due to the timing
(BRP). Room 3G41, NIAID/NIH/DHHS, 5601 Fishers
limitations imposed by the review and
Date: January 27, 2017. Lane, Bethesda, MD 20892–7616, 240–669–
funding cycle. 5067, pamstad@niaid.nih.gov.
Time: 11:00 a.m. to 5:00 p.m. (Catalogue of Federal Domestic Assistance
Agenda: To review and evaluate grant Name of Committee: National Institute of
Program Nos. 93.866, Aging Research, Allergy and Infectious Diseases Special
applications. National Institutes of Health, HHS)
Place: National Institutes of Health, 6701 Emphasis Panel NIAID Clinical Trial
Rockledge Drive, Bethesda, MD 20892. Dated: December 23, 2016. Implementation Cooperative Agreement
Contact Person: Songtao Liu, MD, Melanie J. Pantoja, (U01).
Scientific Review Officer, Center for Date: January 26, 2017.
Program Analyst, Office of Federal Advisory Time: 11:30 a.m. to 1:30 p.m.
Scientific Review, National Institutes of Committee Policy.
Health, 6701 Rockledge Drive, Room 5108, Agenda: To review and evaluate grant
[FR Doc. 2016–31608 Filed 12–28–16; 8:45 am] applications.
Bethesda, MD 20817, 301–435–3578,
songtao.liu@nih.gov. BILLING CODE 4140–01–P Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892,
(Catalogue of Federal Domestic Assistance (Telephone Conference Call).
Program Nos. 93.306, Comparative Medicine; Contact Person: Paul A. Amstad, Ph.D.,
93.333, Clinical Research, 93.306, 93.333, DEPARTMENT OF HEALTH AND
Scientific Review Officer, Scientific Review
93.337, 93.393–93.396, 93.837–93.844, HUMAN SERVICES
Program, Division of Extramural Activities,
93.846–93.878, 93.892, 93.893, National Room 3G41, NIAID/NIH/DHHS, 5601 Fishers
Institutes of Health, HHS) National Institutes of Health Lane, Bethesda, MD 20892–7616, 240–669–
Dated: December 23, 2016. 5067, pamstad@niaid.nih.gov.
National Institute of Allergy and
Anna Snouffer, (Catalogue of Federal Domestic Assistance
Infectious Diseases; Notice of Closed
Program Nos. 93.855, Allergy, Immunology,
Deputy Director, Office of Federal Advisory Meetings and Transplantation Research; 93.856,
Committee Policy.
Microbiology and Infectious Diseases
[FR Doc. 2016–31565 Filed 12–28–16; 8:45 am] Pursuant to section 10(d) of the Research, National Institutes of Health, HHS)
BILLING CODE 4140–01–P Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is Dated: December 23, 2016.
hereby given of the following meetings. Natasha M. Copeland,
DEPARTMENT OF HEALTH AND The meetings will be closed to the Program Analyst, Office of Federal Advisory
HUMAN SERVICES public in accordance with the Committee Policy.
provisions set forth in sections [FR Doc. 2016–31570 Filed 12–28–16; 8:45 am]
National Institutes of Health 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., BILLING CODE 4140–01–P

National Institute on Aging; Notice of as amended. The grant applications and
Closed Meeting the discussions could disclose
confidential trade secrets or commercial DEPARTMENT OF HEALTH AND
Pursuant to section 10(d) of the property such as patentable material, HUMAN SERVICES
Federal Advisory Committee Act, as and personal information concerning
amended (5 U.S.C. App.), notice is National Institutes of Health
individuals associated with the grant
hereby given of the following meeting. applications, the disclosure of which National Institute of Mental Health;
The meeting will be closed to the would constitute a clearly unwarranted Notice of Closed Meeting
public in accordance with the invasion of personal privacy.
provisions set forth in sections Pursuant to section 10(d) of the
Name of Committee: National Institute of
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Allergy and Infectious Diseases Special
Federal Advisory Committee Act, as
as amended. The grant applications and Emphasis Panel NIAID Clinical Trial amended (5 U.S.C. App.), notice is
the discussions could disclose Implementation Cooperative Agreement hereby given of the following meeting.
confidential trade secrets or commercial (U01). The meeting will be closed to the
property such as patentable material, Date: January 23, 2017. public in accordance with the
and personal information concerning Time: 1:30 p.m. to 3:30 p.m. provisions set forth in sections
individuals associated with the grant Agenda: To review and evaluate grant 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
applications. as amended. The grant applications and
asabaliauskas on DSK3SPTVN1PROD with NOTICES

applications, the disclosure of which
would constitute a clearly unwarranted Place: National Institutes of Health, 5601 the discussions could disclose
Fishers Lane, Rockville, MD 20892, confidential trade secrets or commercial
invasion of personal privacy. (Telephone Conference Call).
property such as patentable material,
Name of Committee: National Institute on Contact Person: Paul A. Amstad, Ph.D.,
Aging Special Emphasis Panel, Developing Scientific Review Officer, Scientific Review and personal information concerning
Infrastructure for Interdisciplinary Aging Program, Division of Extramural Activities, individuals associated with the grant
Research. Room 3G41, NIAID/NIH/DHHS, 5601 Fishers applications, the disclosure of which
Date: January 19, 2017. Lane, Bethesda, MD 20892–7616, 240–669– would constitute a clearly unwarranted
Time: 3:00 p.m. to 5:00 p.m. 5067, pamstad@niaid.nih.gov. invasion of personal privacy.

VerDate Sep<11>2014 18:41 Dec 28, 2016 Jkt 241001 PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 E:\FR\FM\29DEN1.SGM 29DEN1

Document Created: 2016-12-29 01:58:18
Document Modified: 2016-12-29 01:58:18

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		January 23, 2017.
FR Citation		81 FR 96026

81 FR 96026 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 250 (December 29, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health